Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
$0.60
-10.9%
$1.55
$0.59
▼
$5.36
$54.83M1.241.20 million shs1.64 million shs
7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
-10.86%-36.26%-56.25%-81.64%-83.47%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
$0.60
-10.9%
$1.55
$0.59
▼
$5.36
$54.83M1.241.20 million shs1.64 million shs
7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
-10.86%-36.26%-56.25%-81.64%-83.47%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
2.50
Moderate Buy$21.333,485.43% Upside

Current Analyst Ratings Breakdown

Latest AVXL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/8/2026
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
Reiterated RatingSell (E+)
(Data available from 11/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
N/AN/AN/AN/A$1.10 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
-$46.38M-$0.15N/AN/AN/AN/A-11.43%-10.72%11/24/2026 (Estimated)

Latest AVXL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/24/2026Q4 2026
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
-$0.11N/AN/AN/AN/AN/A
8/25/2026Q3 2026
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
-$0.08$0.08+$0.16$0.08N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
N/A
15.62
15.62

Institutional Ownership

CompanyInstitutional Ownership
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
31.55%

Insider Ownership

CompanyInsider Ownership
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
11.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
3492.70 million82.13 millionOptionable

Recent News About These Companies

Anavex Life Sciences Corp. (AVXL)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Anavex Life Sciences stock logo

Anavex Life Sciences NASDAQ:AVXL

$0.60 -0.07 (-10.86%)
Closing price 11/20/2026 03:59 PM Eastern
Extended Trading
$0.61 +0.02 (+3.19%)
As of 11/20/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases. Its lead product candidate is ANAVEX 2-73 for the treatment of Alzheimer's disease and Parkinson's disease, as well as other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder; and infantile spasms, Fragile X syndrome, and Angelman syndrome. The company's drug candidate also comprises ANAVEX 3-71, which is in clinical trial for the treatment of schizophrenia, frontotemporal dementia, and Alzheimer's disease. Its preclinical drug candidates include ANAVEX 1-41 for the treatment of depression, stroke, and neurogenerative disease; ANAVEX 1066 for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. The company was incorporated in 2004 and is headquartered in New York, New York.